For sales

Highlights from the Week of 16th March 2026 – 23rd March 2026 in the world of pharma and healthcare!

Highlights from the Week of 16th March 2026 - 23rd March 2026 ( FDA, Approval ) FDA grants approval to Rhythm Pharmaceuticals' IMCIVREE as a label expansion to treat acquired hypothalamic obesity in patients aged 4 years and older ( FDA, Approval ) Novo Nordisk's WEGOVY HD 7.2 mg gains FDA approval to reduce excess body weight and maintain long‑term weight reduction, based on results from the STEP UP trial ( FDA, Approval ) Johnson & Johnson receives FDA approval for ICOTYDE, an IL-23R-targeted oral peptide for treating moderate-to-severe plaque psoriasis ( FDA, Approval ) FDA approves GSK's LYNAVOY, an IBAT inhibitor, to treat cholestatic pruritus in patients with primary biliary cholangitis Pg 1/3 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.